MG
INVE icon

Michael Gelband’s Identive INVE Stock Holding History

Michael Gelband’s Portfolio INVE Stock Details INVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,298
Closed -$97K – 1735
2024
Q1 		$97K Sell
12,298
-28,003
-69% -$223K ﹤0.01% 1416
2023
Q4 		$332K Buy
+40,301
New +$284K ﹤0.01% 1150

Other funds holding INVE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Michael Gelband's INVE Position: Q2 2024 in Review

Michael Gelband sold out of Identive (INVE) in Q2 2024, closing a stake of 12,298 shares — an estimated $97K sold.

Michael Gelband first reported a position in INVE in Q4 2023 and held it in 2 quarters. The position peaked at $332K in Q4 2023. 55 funds tracked by Wall St. Rank hold INVE as of Q2 2024.

  • Michael Gelband reported no remaining Identive position as of Q2 2024 after selling out during the quarter.
  • Michael Gelband sold 12,298 Identive shares in Q2 2024, an estimated $97K.
  • Michael Gelband first reported a position in Identive in Q4 2023 and held it in 2 quarters.
  • Michael Gelband's Identive position peaked at $332K in Q4 2023.
  • 55 funds tracked by Wall St. Rank held Identive as of Q2 2024.

Based on ExodusPoint Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.